Tenax Therapeutics, Inc.
TENX
$6.00
-$0.04-0.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -31.48M | -24.21M | -17.60M | -14.56M | -12.57M |
| Total Depreciation and Amortization | -- | -- | -- | 5.10K | 6.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.74M | 5.16M | 1.15M | 218.80K | 243.20K |
| Change in Net Operating Assets | 1.90M | 2.44M | 1.64M | 1.88M | 869.50K |
| Cash from Operations | -19.84M | -16.61M | -14.81M | -12.46M | -11.45M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 200.00 | 200.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 200.00 | 200.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -278.90K | -412.90K | -500.90K | -675.00K | -567.50K |
| Issuance of Common Stock | 92.58M | 92.30M | 91.95M | 91.95M | 1.00K |
| Repurchase of Common Stock | -100.24M | -100.24M | -100.24M | -14.19M | -14.48M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 123.86M | 123.86M | 108.65M | 22.54M | 22.49M |
| Cash from Financing | 115.92M | 115.51M | 99.87M | 99.63M | 7.44M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.08M | 98.90M | 85.06M | 87.17M | -4.01M |